Back to Search
Start Over
In Silico Categorization of in Vivo Intrinsic Clearance Using Machine Learning
- Source :
- Molecular Pharmaceutics. 10:1318-1321
- Publication Year :
- 2013
- Publisher :
- American Chemical Society (ACS), 2013.
-
Abstract
- Machine learning has recently become popular and much used within the life science research domain, e.g., for finding quantitative structure-activity relationships (QSARs) between molecular structures and different biological end points. In the work presented here, we have applied orthogonal partial least-squares (OPLS), principal component analysis (PCA), and random forests (RF) methods for classification as well as regression analysis to a publicly available in vivo data set in order to assess the intrinsic metabolic clearance (CL(int)) in humans. The derived classification models are able to identify compounds with CL(int) lower and higher than 1500 mL/min, respectively, with nearly 80% accuracy. The most relevant descriptors are of lipophilicity and charge/polarizability types. Furthermore, the accuracy from a classification model based on regression analysis, using the 1500 mL/min cutoff, is also around 80%. These results suggest the usefulness of machine learning techniques to derive robust and predictive models in the area of in vivo ADMET (absorption, distribution, metabolism, elimination, and toxicity) modeling.
- Subjects :
- Quantitative structure–activity relationship
In silico
Quantitative Structure-Activity Relationship
Pharmaceutical Science
Machine learning
computer.software_genre
Absorption
Artificial Intelligence
Drug Discovery
Humans
Cutoff
Computer Simulation
Least-Squares Analysis
Mathematics
Principal Component Analysis
Models, Statistical
OPLS
business.industry
Reproducibility of Results
Regression analysis
Random forest
Data set
Drug Design
Principal component analysis
Regression Analysis
Molecular Medicine
Artificial intelligence
business
computer
Software
Subjects
Details
- ISSN :
- 15438392 and 15438384
- Volume :
- 10
- Database :
- OpenAIRE
- Journal :
- Molecular Pharmaceutics
- Accession number :
- edsair.doi.dedup.....1c80cefafe3229769d0542fcdc36d641
- Full Text :
- https://doi.org/10.1021/mp300484r